Insights

Innovative Dysphagia Treatment Phagenesis offers a non-invasive, clinically validated neurostimulation device, the Phagenyx, positioning it as a leader in cutting-edge dysphagia care solutions ideal for healthcare providers looking to adopt advanced therapies.

Strong Funding Growth Recent Series D funding of $42 million underscores investor confidence and provides capital for expanding sales efforts, developing new features, and entering new markets within the medical device sector.

Leadership Expansion The appointment of a new CEO and board members indicates strategic growth and potential for scaling sales operations, making the company a promising partner for distributors and healthcare distributors worldwide.

Market Demand Potential With millions affected by swallowing difficulties globally, there is significant sales potential in hospitals, rehabilitation centers, and clinics seeking innovative treatments that improve patient outcomes and differentiate their offerings.

Technology & Certification Utilizing proven neurostimulation technology and adhering to safety standards, Phagenesis's product appeals to healthcare providers prioritizing evidence-based, effective, and non-invasive treatment options for dysphagia.

Similar companies to Phagenesis

Phagenesis Tech Stack

Phagenesis uses 8 technology products and services including Site Kit, MySQL, Supersized, and more. Explore Phagenesis's tech stack below.

  • Site Kit
    Analytics
  • MySQL
    Database
  • Supersized
    Javascript Libraries
  • Bricks
    Page Builders
  • Priority Hints
    Performance
  • Yoast SEO
    Search Engines
  • WPML
    Web Platform Extensions
  • Apache
    Web Servers

Media & News

Phagenesis's Email Address Formats

Phagenesis uses at least 1 format(s):
Phagenesis Email FormatsExamplePercentage
First.Last@phagenesis.comJohn.Doe@phagenesis.com
48%
FirstLast@phagenesis.comJohnDoe@phagenesis.com
2%
First.Last@phagenesis.comJohn.Doe@phagenesis.com
48%
FirstLast@phagenesis.comJohnDoe@phagenesis.com
2%

Frequently Asked Questions

Where is Phagenesis's headquarters located?

Minus sign iconPlus sign icon
Phagenesis's main headquarters is located at Manchester, England m15 6se United Kingdom. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Phagenesis's phone number?

Minus sign iconPlus sign icon
You can contact Phagenesis's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Phagenesis's official website and social media links?

Minus sign iconPlus sign icon
Phagenesis's official website is phagenesis.com and has social profiles on LinkedIn.

What is Phagenesis's NAICS code?

Minus sign iconPlus sign icon
Phagenesis's NAICS code is 33911 - Medical Equipment and Supplies Manufacturing.

How many employees does Phagenesis have currently?

Minus sign iconPlus sign icon
As of February 2026, Phagenesis has approximately 55 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Coo: C. M.Chief Financial Officer: M. K.Vice President Sales, Eu: N. W.. Explore Phagenesis's employee directory with LeadIQ.

What industry does Phagenesis belong to?

Minus sign iconPlus sign icon
Phagenesis operates in the Medical Equipment Manufacturing industry.

What technology does Phagenesis use?

Minus sign iconPlus sign icon
Phagenesis's tech stack includes Site KitMySQLSupersizedBricksPriority HintsYoast SEOWPMLApache.

What is Phagenesis's email format?

Minus sign iconPlus sign icon
Phagenesis's email format typically follows the pattern of First.Last@phagenesis.com. Find more Phagenesis email formats with LeadIQ.

When was Phagenesis founded?

Minus sign iconPlus sign icon
Phagenesis was founded in 2007.

Phagenesis

Medical Equipment ManufacturingEngland, United Kingdom51-200 Employees

Welcome to the Phagenesis LinkedIn page! 

At Phagenesis, we are dedicated to transforming the way dysphagia is treated. 
 Dysphagia, or difficulty swallowing, can be a debilitating condition that affects millions of people worldwide. 

We believe that everyone deserves the ability to enjoy their meals and live their lives to the fullest, which is why we have developed the Phagenyx - a revolutionary product that uses Pharyngeal Electrical Stimulation (PES) to treat dysphagia. 

The Phagenyx is a simple, non-invasive device that stimulates the nerves in the pharynx, helping patients regain control of their swallowing function. Our product has been rigorously tested in clinical trials and has been shown to significantly improve swallowing ability in patients with dysphagia. 

As a company, we are committed to advancing the field of dysphagia care through innovative technology and evidence-based practices. We work closely with healthcare providers and patients to ensure that our product meets the highest standards of safety and efficacy. 

We are proud to be changing the paradigm of dysphagia care, and we invite you to join us in our mission to improve the lives of millions of people around the world. Follow our page to stay up-to-date on the latest news and developments in dysphagia care, and to learn more about the Phagenyx and how it is helping patients overcome dysphagia.

Section iconCompany Overview

Headquarters
Manchester, England m15 6se United Kingdom
Phone number
NAICS Code
33911 - Medical Equipment and Supplies Manufacturing
Founded
2007
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    Phagenesis's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Phagenesis's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.